Ethylene-vinyl alcohol copolymer-based non-adhesive liquid embolic agent for transcatheter arterial embolization in patients with abdominal/pelvic arterial bleeding: A prospective, single-arm, multicenter cohort study
Diagnostic and Interventional Imaging · 2025
DOI: 10.1016/j.diii.2025.02.001 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Diagnostic and Interventional Imaging, 2025. Verfasst von Romaric Loffroy und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular and Interventional Radiology, Image-Guided Therapy Center, François-Mitterrand University Hospital, 21079 Dijon, France; ICMUB…. Hauptthemen laut MEDLINE: Polyvinyls, Embolization, Therapeutic, Hemorrhage, Pelvis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: The purpose of this study was to evaluate the safety and efficacy of a novel ethylene-vinyl alcohol copolymer-based non-adhesive liquid embolic agent for transcatheter arterial embolization (TAE) in patients with bleeding from abdominal and/or pelvic arteries MATERIALS AND METHODS: A prospective observational multicenter study (Clinicaltrials.gov Identifier: NCT04787120) included consecutive patients treated with TAE using a novel ethylene-vinyl alcohol copolymer-based non-adhesive liquid embolic agent (SQUIDPERI 18) at four university hospitals from 2021 to 2023. The indication for TAE included acute symptomatic bleeding or imminent risk of bleeding from visceral (n = 63), muscular (n = 23), or gastrointestinal (n = 29) abdominal/pelvic arteries combined with angiographic abnormalities. Patient characteristics, clinical success rates, and interventional-radiologist satisfaction with each TAE were assessed. Clinical success at 1- and 6 months was defined as survival without reintervention for rebleeding from the initially embolized site(s). Univariable and multivariable analyses were performed to identify variables associated with clinical failure of TAE. RESULTS: Of the 110 patients enrolled, 104 had 1-month and 98 had 6-month data. Target vessel(s) were successfully occluded in 108 of the 110 patients, resulting in a technical success rate of 98.2 %. Clinical success rates at 1 and 6 months were 72.1 % (75/104 patients) and 64.3 % (63/98 patients), respectively. Mortality was 20/104 (19.2 %) at 1 month and 26/98 (26.5 %) at 6 months. One patient experienced an adverse event during TAE. The rates of adverse events and serious adverse events at 1 month were 31.4 % (32/102) and 22.5 % (23/102), respectively. Older age was the single variable associated with clinical failure of TAE at 1 month in both univariable and multivariable analysis. In more than 90 % of TAEs, the interventional radiologists were satisfied for five of the seven questionnaire items. CONCLUSION: The novel ethylene-vinyl alcohol copolymer-based non-adhesive liquid embolic agent is safe and effective for TAE in patients presenting with acute symptomatic bleeding from abdominal/pelvic arteries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular and Interventional Radiology, Image-Guided Therapy Center, François-Mitterrand University Hospital, 21079 Dijon, France; ICMUB Laboratory, UMR CNRS 6302, University of Burgundy, 21000 Dijon, Franc…
- Medical Imaging Department, Hôpital Henri-Mondor, AP-HP, 94000 Créteil, France.
- Interventional Radiology Section, Department of Medical Imaging, Timone University Hospital, AP-HM, 13385 Marseille, France; Aix Marseille Université, LIIE & CERIMED, 13005 Marseille, France.
- Department of Medical Imaging, IPI Plateform, Nîmes University Hospital, 30029 Nîmes, France.
- Department of Vascular and Oncological Interventional Radiology, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France; Université Paris Cité, PARCC-INSERM Unité 970, 75015 Paris, France.
- Department of Vascular and Oncological Interventional Radiology, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France.
Zitieren
APA
Loffroy, R., Kobeiter, H., Vidal, V., Frandon, J., Pellerin, O., Dean, C., Sammoud, S., Vernhet-Kovacsik, H., Derbel, H., Aho-Glélé, L. S., Chevallier, O., & Sapoval, M. (2025). Ethylene-vinyl alcohol copolymer-based non-adhesive liquid embolic agent for transcatheter arterial embolization in patients with abdominal/pelvic arterial bleeding: A prospective, single-arm, multicenter cohort study. Diagnostic and Interventional Imaging. https://doi.org/10.1016/j.diii.2025.02.001
Vancouver
Loffroy R, Kobeiter H, Vidal V, Frandon J, Pellerin O, Dean C, et al. Ethylene-vinyl alcohol copolymer-based non-adhesive liquid embolic agent for transcatheter arterial embolization in patients with abdominal/pelvic arterial bleeding: A prospective, single-arm, multicenter cohort study. Diagnostic and Interventional Imaging. 2025. doi:10.1016/j.diii.2025.02.001
BibTeX
@article{Loffroy2025,
author = {Loffroy, Romaric and Kobeiter, Hicham and Vidal, Vincent and Frandon, Julien and Pellerin, Olivier and Dean, Carole and Sammoud, Skander and Vernhet-Kovacsik, Hélène and Derbel, Haytham and Aho-Glélé, Ludwig-Serge and Chevallier, Olivier and Sapoval, Marc},
title = {Ethylene-vinyl alcohol copolymer-based non-adhesive liquid embolic agent for transcatheter arterial embolization in patients with abdominal/pelvic arterial bleeding: A prospective, single-arm, multicenter cohort study},
journal = {Diagnostic and Interventional Imaging},
year = {2025},
doi = {10.1016/j.diii.2025.02.001}
}
EUVIMED